Exosens Shares Bounce Back 2.5% After Record Deal with Czech Army
The French night vision technology specialist regains momentum in mid-morning trading, driven by the announcement of a long-term agreement with the Czech armed forces. The rebound comes after several sessions of correction that brought the stock close to its technical support.
A Record Contract with Prague Until 2032 Revives the Stock
Exosens shares gain 2.59% to €55.55 during the session, while the SBF 120 drops 0.36%. The stock is among the top gainers in the SBF 120, although not leading the segment, which is occupied by Soitec. The movement reflects the multi-year agreement signed with Brolis to supply the Czech armed forces with about 17,000 image intensifier tubes, to be delivered by 2032. Prague has never placed such a large order in this field, providing unusual industrial visibility towards the end of the decade. This rebound follows a challenging period, with the stock losing nearly 20% over a month and 7.57% over the past week, after several documented support breaks in recent days, including one following the securing of a €140 million credit facility from the EIB.
Technical Rebound Initiated on Support at €52.65 with RSI in Oversold Zone
The stock price reacts from the support level identified at €52.65, after a slide that had led the stock into an oversold zone. The RSI at 34 indicates this selling exhaustion and accompanies today's rebound, without signaling a lasting reversal at this stage. The medium-term configuration remains fragile: the price is trading below the MM20 (€59.97, a gap of -7.37%) and the MM50 (€61.82, a gap of -10.14%), both levels acting as resistances if the rebound extends. However, the stock maintains above the MM200 (€54.81, a gap of +1.35%), a line that still separates the movement from a more marked degradation. The next area to watch remains the resistance at €69.20, still distant, while the performance over one year remains positive at +37.33%.
